Clinical and molecular features of papillary thyroid cancer in adolescents and young adults

Cancer

Volumn 117, Issue 2, 2011, Pages 259-267

  Vriens, Menno R ^a   Moses, Willieford ^a   Weng, Julie ^a   Peng, Miao ^a   Griffin, Ann ^c   Bleyer, Archie ^d   Pollock, Brad H ^e   Indelicato, Daniel J ^f   Hwang, Jimmy ^b   Kebebew, Electron ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OREGON   (United States)

^e University of Texas Health Science Center at San Antonio   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

adolescents; genomics; oncogenes; thyroid cancer; young adults

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE GENE; ADOLESCENT; ADULT; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CARBONIC ANHYDRASE II GENE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EPIDERMAL GROWTH FACTOR RECEPTOR 2 GENE; EXTRACELLULAR MATRIX PROTEIN 1 GENE; FEMALE; FRUCTOSE 2,6 BISPHOSPHATASE 2 GENE; GENE; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; HUMAN GENOME; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEIS HOMEOBOX 2 GENE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PAPILLARY THYROID CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; SOMATIC MUTATION; THYROID CANCER; URINARY PLASMINOGEN ACTIVATOR GENE;

ADOLESCENT; ADULT; CARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MALE; MUTATION; NEOPLASM METASTASIS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 78650988256     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25369     Document Type: Article

References (26)

1. Davies L, Welch H,. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.
2. Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008; 144: 1038-1043.
3. Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8: 288-298. (Pubitemid 351430865)
4. Ferrari F, Montello M, Budd T, et al. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer. 2008; 50: 1101-1104.
5. Hod N, Hagag P, Baumer M, et al. Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment. Clin Nucl Med. 2005; 30: 387-390.
6. Miccoli P, Minuto M, Ugolini C, et al. Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age. Otolaryngology. 2008; 138: 200-203.
7. Kebebew E, Peng M, Reiff E, et al. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Surgery. 2005; 138: 1102-1109.
8. Kebebew E, Peng M, Reiff E, et al. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg. 2005; 242: 353-361.
9. Kebebew E, Peng M, Reiff E, et al. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer. 2006; 106: 2592-2597.
10. Subramaniana A, Tamayoa P, Moothaa VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS. 2005; 102: 15545-15550.
11. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34: 267-273.
12. Kumar Das D,. Age of patients with papillary thyroid carcinoma: is it a key factor in the development of variants? Gerontology. 2005; 51: 149-154.
13. Haymart M,. Understanding the relationship between age and thyroid cancer. Oncologist. 2009; 14: 216-221.
14. Kebebew E, Weng J, Bauer J, et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg. 2007; 246: 466-471.
15. Klugbauer S, Lengfelder E, Demidchik EP, et al. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene. 1995; 11: 2459-2467. (Pubitemid 26023813)
16. Henderson Y, Shellenberger TD, Williams MD, et al. High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin Cancer Res. 2009; 15: 485-491.
17. Wang YL, Wang JC, Wu Y, et al. Incidentally simultaneous occurrence of RET/PTC, H4-PTEN and BRAF mutation in papillary thyroid carcinoma. Cancer Lett. 2008; 263: 44-52.
18. Garcia-Roston G, Zhao H, Camp L, et al. Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol. 2003; 21: 3226-3235.
19. Nikiforov Y, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009; 94: 2092-2098.
20. Pauws E, Veenboer GJ, Smit JW, et al. Genes differently expressed in thyroid carcinoma identified by comparison of SAGE expression profiles. FASEB J. 2004; 18: 560-561.
21. Freudenberg LS, Shue S, Gorges R, et al. Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma. Nuklearmedizin. 2005; 44: 179-184.
22. Chu QD, Hurd TC, Harvey S, et al. Overexpression of urinary plasminogen activator (UPA) protein and mRNA in thyroid carcinogenesis. Diagn Mol Pathol. 2004; 13: 241-246.
23. Ulisse S, Baldini E, Toller M, et al. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas. Eur J Cancer. 2006; 42: 2631-2638.
24. Herceg GH, Herceg D, Kralik M, et al. Urokinase-type plasminogen activator and its inhibitor in thyroid neoplasms: a cytosol study. Wien Klin Wochenschr. 2006; 20: 601-609.
25. Kummola L, Hamalainen JM, Kivela J, et al. Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa [serial online]. BMC Cancer. 2005; 18: 41.
26. Hosoda H, Okawa-Takatsuji M, Shinmura W, et al. Potential for differential diagnosis of autoimmune pancreatitis and pancreatic cancer using carbonic anhydrase II antibody [serial online]. Pancreas. 2008; 37: e1-e7.